Literature DB >> 12190998

Expression of resistin in the adipose tissue is modulated by various factors including peroxisome proliferator-activated receptor alpha.

Y Fukui1, K Motojima.   

Abstract

AIM: Resistin has been suggested to link obesity to diabetes by antagonizing insulin action. However, this model is based on limited observations and how resistin links the two complex processes is not known. In this study, we investigated the effects of various factors on the expression of resistin and examined the generality of the proposal.
METHODS: Total RNA was isolated from the adipose tissues of lean, obese and peroxisome proliferator-activated receptor (PPAR)alpha-null mice fed a control diet or that contained a PPAR ligand, and analysed by Northern blotting using cDNAs for resistin, leptin, aP2 and other mRNAs as probes. For quantitative analysis, an image analyser was used.
RESULTS: Basal expression of resistin mRNA was suppressed by obesity, but the extent of suppression differed significantly among the mouse strains and types of adipose tissue examined. Anti-diabetic thiazolidinediones induced resistin expression in the lean mice and showed smaller effects in obese mice. Furthermore, PPARalpha was shown to play an important role in constitutive expression of resistin in the adipose tissue.
CONCLUSION: Our results indicated that diverse factors modulate the expression of resistin in the adipose tissues of mice, and suggested that resistin is not a master hormone linking obesity to diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190998     DOI: 10.1046/j.1463-1326.2002.00215.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  7 in total

Review 1.  Regulation of adipocytokines and insulin resistance.

Authors:  M Fasshauer; R Paschke
Journal:  Diabetologia       Date:  2003-11-06       Impact factor: 10.122

2.  The irresistible biology of resistin.

Authors:  Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  The physiological role of resistin and its connection with metabolic diseases.

Authors:  K Motojima
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 4.  Resistin: molecular history and prognosis.

Authors:  Ronadip R Banerjee; Mitchell A Lazar
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

5.  Role of resistin in diet-induced hepatic insulin resistance.

Authors:  Evan D Muse; Silvana Obici; Sanjay Bhanot; Brett P Monia; Robert A McKay; Michael W Rajala; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity.

Authors:  Kee-Hong Kim; Ling Zhao; Yangsoo Moon; Chulho Kang; Hei Sook Sul
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-16       Impact factor: 11.205

7.  Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabolic determinants or insulin resistance.

Authors:  Jong Chul Won; Cheol-Young Park; Won Young Lee; Eon Sook Lee; Sang Woo Oh; Sung Woo Park
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.